US Stock MarketDetailed Quotes

TEVA Teva Pharmaceutical Industries

Watchlist
  • 16.250
  • -0.380-2.29%
Close Feb 14 16:00 ET
  • 16.350
  • +0.100+0.62%
Post 20:01 ET
18.42BMarket Cap-11.21P/E (TTM)

Teva Pharmaceutical Industries Key Stats

Teva Pharmaceutical Industries Q4 2024 Earnings Date

Currency:USDJan 29, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
4.12B
4.23B
+112.34M
Beat Est.
-7.64%
-5.12%
+2.73%
EPS
0.26
-0.19
-0.45
Miss Est.
-35.44%
-146.34%
-171.78%
Strong Buy

Feb 17, 2025

Teva Pharmaceutical Industries Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 4.309B--
--2025/Q1-- / 3.998B--
Jan 29, 20252024/Q44.229B / 4.117B--
Nov 6, 20242024/Q34.332B / 4.125B--
Jul 31, 20242024/Q24.164B / 4.045B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 4.309B--
--2025/Q1-- / 3.998B--
Jan 29, 20252024/Q44.229B / 4.117B--
Nov 6, 20242024/Q34.332B / 4.125B--
Jul 31, 20242024/Q24.164B / 4.045B--

Unlock Free Earnings Estimates

Teva Pharmaceutical Industries Earnings Reports

Read more

Trending Stocks

Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve Show More